Cingulate Inc (CING)

Short Interest in Cingulate Inc. (NASDAQ:CING) Expands By 1390.9% - Defense World

Defense World

Cingulate Inc. Stockholders Bolster Governance and Growth Strategy - TipRanks.com - TipRanks

TipRanks

Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update - br.ADVFN.com

br.ADVFN.com

Market Recap Check: Cingulate Inc (CING)'s Negative Finish at 0.79, Up/Down -4.40 – DWinneX - The Dwinnex

The Dwinnex

A Look at Cingulate Inc (CING) Shares in the Recent Past Indicates Growth – Sete News - SETE News

SETE News

A History of Outperforming Analyst Forecasts and Beating the Odds: Cingulate Inc (CING) – Sete News - SETE News

SETE News

FDA Clears Cingulate to File NDA for CTx-1301 in the Treatment of ADHD - Psychiatric Times

Psychiatric Times

CING’s Debt-to-Equity Ratio at 0.13: What It Means for Cingulate Inc’s Future - The InvestChronicle

The InvestChronicle

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD - Markets Insider

Markets Insider

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD - GlobeNewswire

GlobeNewswire

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD - Yahoo Finance

Yahoo Finance

FDA Clears Cingulate to File NDA for CTx-1301 in the Treatment of ADHD - Psychiatric Times

Psychiatric Times

Cingulate resolves threat of having its stock delisted - The Business Journals

The Business Journals

Cingulate resolves threat of having its stock delisted - The Business Journals

The Business Journals

CING Stock Earnings: Cingulate Beats EPS for Q1 2024 - MSN

MSN

Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update - Markets Insider

Markets Insider

Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update - Yahoo Finance

Yahoo Finance

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured ... - GlobeNewswire

GlobeNewswire

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured ... - Yahoo Finance

Yahoo Finance

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured ... - Yahoo Finance

Yahoo Finance

Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024

GlobeNewswire Inc.

Cingulate CEO Shane Schaffer - Kansas City Business Journal - The Business Journals

The Business Journals

Cingulate can add $3.5M to latest stock offering as it navigates FDA drug approval - Kansas City Business Journal - The Business Journals

The Business Journals

Cingulate to Participate in Benzinga All Live Access Event

GlobeNewswire Inc.

Cingulate to Participate in Benzinga All Live Access Event - GlobeNewswire

GlobeNewswire

Cingulate to Attend DCAT Week 2024 in New York City

GlobeNewswire Inc.

Cingulate to Attend DCAT Week 2024 in New York City - GlobeNewswire

GlobeNewswire

Cingulate regains compliance with Nasdaq, maintaining key capital source - The Business Journals

The Business Journals

Cingulate adds members to board of directors - Kansas City Business Journal - The Business Journals

The Business Journals

Cingulate Inc Bolsters Board, Targets Nasdaq Compliance - TipRanks.com - TipRanks

TipRanks

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors

GlobeNewswire Inc.

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors - GlobeNewswire

GlobeNewswire

Pharma company Cingulate raises $7.5M from public offering - The Business Journals

The Business Journals

Healthcare Stocks Moving Wednesday: OGEN, FEMY, JSPR, ABEO, GDTC, CING, HUMA, NEXI - InvestorsObserver

InvestorsObserver

Cingulate Announces Closing of $7.5 Million Public Offering

GlobeNewswire Inc.

Cingulate Announces Closing of $7.5 Million Public Offering - Yahoo Finance

Yahoo Finance

Peering Into Cingulate's Recent Short Interest By Benzinga - Investing.com UK

Investing.com UK

S&P 500 Gains Over 1%; Amazon Earnings Top Expectations

Benzinga

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings

Benzinga

Dow Falls 150 Points; US Economy Adds 353,000 Jobs In January

Benzinga

Cingulate prices 3.75M shares at $2.00 in public offering - TipRanks.com - TipRanks

TipRanks

Cingulate Announces Pricing of $7.5 Million Public Offering

GlobeNewswire Inc.

Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Benzinga

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.35% By Investing.com - Investing.com

Investing.com

Cingulate Inc Welcomes New CFO Jennifer Callahan - TipRanks.com - TipRanks

TipRanks

Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

GlobeNewswire Inc.

Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market

GlobeNewswire Inc.

Cingulate promotes exec to CFO amid dwindling capital - The Business Journals

The Business Journals

Cingulate prepares another stock offering to raise money amid funding crunch - The Business Journals

The Business Journals